Quick Answer
HeartSciences Inc. reported Revenue (ASC 606) of $4.3 thousand for fiscal year 2025.
HeartSciences Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $4.3K | -76.6% |
| 2024 | $18.6K | +261.2% |
| 2023 | $5.2K | -64.2% |
| 2022 | $14.4K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $0.00 | — | -100.0% |
| October 31, 2025 | $2.4K | — | +27.3% |
| July 31, 2025 | $1.9K | — | — |
| January 31, 2025 | $0.00 | -100.0% | -100.0% |
| January 31, 2024 | $14.7K | +653.8% | +276.9% |
| October 31, 2023 | $3.9K | — | +100.0% |
| January 31, 2023 | $1.9K | -28.8% | -39.1% |
| July 31, 2022 | $3.2K | -57.2% | +16.8% |
- HeartSciences Inc. showed a decrease of -76.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2022–2025 period, HeartSciences Inc.’s revenue (asc 606) has declined by 69.7% (from $14.4 thousand to $4.3 thousand).
- The most recent figure is from HeartSciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: